Hsp72 recognizes a P binding motif in the measles virus N protein C-terminus  by Zhang, Xinsheng et al.
www.elsevier.com/locate/yviroVirology 337 (20Hsp72 recognizes a P binding motif in the measles virus
N protein C-terminus
Xinsheng Zhanga, Jean-Marie Bourhisb, Sonia Longhib, Thomas Carsilloc, Matthew Buccellatoa,
Benjamin Morinb, Bruno Canardb, Michael Oglesbeea,c,*
aDepartment of Veterinary Biosciences, The Ohio State University, 1925 Coffey Road, Columbus, OH 43210, USA
bArchitecture et Fonction de Macromole´cules Biologiques, UMR 6098 CNRS and Universities Aix-Marseille I and II, 13288 Marseille Cedex 09, France
cDepartment of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA
Received 17 January 2005; returned to author for revision 17 February 2005; accepted 30 March 2005
Available online 26 April 2005Abstract
The major inducible 70-kDa heat shock protein (hsp72) binds measles virus (MV) nucleocapsids and increases MV gene expression. The
cytoplasmic tail of the MV N protein (NTAIL) contains three hydrophobic domains (Box-1–3) that are potential targets of hsp72 interaction.
Low affinity binding to Box-3 is correlated to hsp72-dependent stimulation of MV minireplicon reporter gene expression whereas
interactions between hsp72 and Box-1 and/or -2 have not been documented. The present work showed that virus deficient in Box-3/hsp72
interaction retains the ability to form nucleocapsid/hsp72 complexes, identifying Box-2 but not Box-1 as a mediator of high affinity hsp72
binding. Box-2 is the binding site for the viral P protein X domain (XD), where P tethers the viral polymerase to nucleocapsid in support of
transcription and genome replication, and competitive inhibition of XD binding to NTAIL by hsp72 was shown. Recognition of a common
binding site by P and hsp72 represents a potential mechanism for host cell modulation of viral gene expression.
D 2005 Elsevier Inc. All rights reserved.Keywords: Hsp72; Measles virus; N protein C-terminusIntroduction
The paramyxovirus nucleocapsid consists of the negative-
strand RNA viral genome packaged by the nucleocapsid
protein (N) to form a helical and filamentous core particle.
This core particle is template for the viral RNA-dependent
RNA-polymerase (L). An essential feature of this template
is the carboxyl terminal 125 amino acids of the N protein
(i.e., NTAIL), an intrinsically disordered domain that is
accessible on the surface of nucleocapsids (Heggeness et
al., 1980, 1981; Longhi et al., 2003). Despite a high
degree of NTAIL sequence variability within the morbilli-
virus genus, there are three conserved regions that are
enriched in hydrophobic residues (Diallo et al., 1994).0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Box-3, corresponding to MV N amino acids 401–420,
489–506, and 517–525, respectively (Fig. 1). The
accessible hydrophobicity represented by these domains
makes them ideal mediators of protein–protein interac-
tions. Box-2 is a target of the viral phosphoprotein (P),
where P serves as a tether between L and the N protein,
this being an essential co-factor function in support of both
transcription and genome replication (Bourhis et al., 2004;
Johansson et al., 2003; Kingston et al., 2004a, 2004b).
Accordingly, deletion of N protein sequences that include
Box-2 results in a dramatic loss of MV minireplicon
reporter gene expression, whereas N proteins with deletion
of more distal residues are functional as template (Zhang
et al., 2002).
The major inducible 70-kDa heat shock protein (hsp72)
binds Box-3 of Edmonston MV (Ed-MV), the prototype
vaccine strain within the group A genotype (Zhang et al.,05) 162 – 174
Fig. 1. Modular organization of the MV N protein showing the N-terminal
assembly domain (N-CORE) and the intrinsically disordered C-terminus
(N-TAIL) which contains three conserved motifs that are enriched in amino
acids with hydrophobic side groups (Box-1–3). Variant N proteins included
a N to D substitution within Box-3 of NTAIL (N-522D) and deletion
constructs lacking either Box-3 (ND3) or both Box-2 and -3 (ND2,3).
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relevant affinity (i.e., KD = 1 AM), similar to that reported
for functional interactions between hsp72 and p53 (Zylicz et
al., 2001), allowing functional interactions to occur under
conditions of elevated hsp72 expression. Box-3 sequence
composition conforms to a linear stretch of 8–9 amino acids
typical of 70-kDa hsp binding targets: it is enriched in
amino acids with hydrophobic and aromatic side groups, has
few acidic side groups, and contains basic side groups that
confer selectivity for hsp72 binding (Fourie et al., 1994;
Gething et al., 1995). Non-group A genotype viruses (i.e.,
wild type viruses) exhibit an asparagine (N) to aspartic acid
(D) substitution at N amino acid 522 (522D), enhancing the
acidic side-group content of the binding target. This change
reduces hsp72 binding affinity by approximately 800-fold,
as shown by surface plasmon resonance analysis of binding
reactions using a Box-3 peptide bearing the N522D
substitution (Zhang et al., 2002). Loss of hsp72 binding
by the 522D variant of Box-3 is associated with an atte-
nuation of hsp72-dependent stimulation of MV minireplicon
reporter gene expression, whereas basal gene expression is
unaltered (Zhang et al., 2002). The mechanistic basis for
hsp72-dependent stimulation of MV gene expression has
not been fully characterized, nor has the role of constitutive
or virus-induced hsp72 levels on the support of basal viral
gene expression and replication, although interactions with
Box-1 and/or Box-2 may play a role. Such second site
interactions are probable, given a sequence composition of
Box-1 and -2 that is predictive of hsp72 binding and the much
higher affinity between hsp72 and nucleocapsids (i.e., KD =
16 nM) than can be accounted for by Box-3 alone (KD =
1 AM) (Zhang et al., 2002).
The present work examines the contribution of Box-1
and -2 to nucleocapsid binding, beginning with the rescue of
a recombinant infectious virus composed of Ed-MV N
proteins carrying the 522D substitution (Ed N-522D). This
allowed documentation of hsp72–nucleocapsid complex
formation where a significant hsp72 binding capacity of
Box-3 is lost. Co-immunoprecipitation of hsp72 and N
protein variants expressed within transfected cells was used
to demonstrate the requirement of Box-2 for hsp72 complex
formation, where N protein expressed in this manner is
known to form nucleocapsid-like particles. Results wereconfirmed using surface plasmon resonance analysis of
binding reactions between hsp72 and variants of a soluble
monomeric form of NTAIL that accurately model hsp72–
nucleocapsid interaction, binding of hsp72 to Box-1–3
peptides, and competitive inhibition of binding reactions
between the P protein X-domain and NTAIL, a Box-2-
mediated interaction supporting both transcription and
genome replication. Analysis of Ed N-522D genome and
transcript levels in cells expressing elevated hsp72 support
the functional significance of hsp72 second site interactions.Results
Nucleocapsid from the N protein 522D variant of Ed-MV
retains the ability to form stable complexes with hsp72
Infectious Ed-MV containing the 522D variant N
sequence (Ed N-522D) was generated by reverse genetics.
Ed N and Ed N-522D viruses were propagated both on
control and pre-conditioned Vero cells. Pre-conditioning is
the state of heightened resistance to diverse protein-
denaturing insults that is mediated by elevated expression
of heat shock proteins, particularly hsp72, and is mediated
by transient exposure to a sublethal stress (e.g., heat shock).
Pre-conditioning was achieved by exposing cells in the log
phase of growth to 43 -C for 1.5 h, then infecting cells at 16
h post-treatment, a time where cells are fully recovered from
the hyperthermic stress yet retain elevated cytoplasmic
levels of hsp72. Persistence of the elevated hsp72 levels
reflects the 48 h half-life of the protein (Mizzen and Welch,
1988). The elevated expression level at the time of infection
was confirmed by Western blot analysis of cell lysates using
monoclonal antibody specific to hsp72 (SPA-810, Stress-
Gen) or monoclonal antibody recognizing an epitope shared
between hsp72 and the constitutively expressed hsp73
(SPA-820, StressGen) (data not shown). Both structural
and functional interactions between hsp72 and MV nucle-
ocapsids have been previously documented under these
conditions (Vasconcelos et al., 1998a, 1998b).
Cytoplasmic nucleocapsids were isolated from Vero cells
at the point of maximal syncytial coverage in the infected
monolayers (i.e.,  90%). The final purification step utilized
CsCl isopycnic density centrifugation, with peak 254 nm
light absorbance identifying nucleocapsids at an average
band density of 1.30 T 0.02 gm/ml. Minus-strand virus-
specific RNA and viral N protein were detected in all
nucleocapsid fractions based upon Northern blot analysis
(data not shown) and Western blot analysis of gradient
fractions (Fig. 2), respectively. Hsp72 was detected only in
nucleocapsid derived from pre-conditioned cells (Fig. 2),
consistent with previous reports (Vasconcelos et al., 1998a,
1998b). Gradient fractions derived from uninfected control
or pre-conditioned cells did not contain cellular proteins at
the density where nucleocapsid was recovered, identical to
previously reported results (Oglesbee et al., 1989a, 1990)
Fig. 2. Characterization of cytoplasmic MV nucleocapsid from pre-
conditioned Vero cells (PC) and non-conditioned control cells (C) infected
with either Ed N or Ed N-522D. Nucleocapsid was purified by CsCl
isopycnic density centrifugation, with nucleocapsid containing fractions
identified based upon absorbance of 254-nm light. Total protein contained
within these fractions was resolved by 12% SDS–PAGE for Western blot
analysis. These blots were probed with monoclonal antibody recognizing
either the N protein or hsp72 (HSP). Hsp72 was detected within
nucleocapsid isolated from pre-conditioned cells, being observed for both
Ed N and Ed N-522D. Positive controls (+) for the Western blots were
MVAT7-infected Hep2 cell lysates transfected with pT7N and pT7VSV-
hsp72, plasmids directing expression of N and hsp72.
Fig. 3. Association of hsp72 and N protein C-terminal variants by co-
immunoprecipitation. Hep2 cells were transfected with plasmid mediating
the T7-mediated expression of an N protein construct, with or without a
similar hsp72 expression construct, using MVAT7 as a source of polyme-
rase. N protein was detected by Western blot analysis of cell lysates (Lys) or
immunoprecipitates (Ippt) formed with antibody against the VSV-G epitope
tag on the hsp72 construct. Results support hsp72 complex formation by N,
N-522D, and ND3, but not ND2,3 or lysates derived from cells lacking
hsp72 overexpression. Results are representative of three experimental
trials.
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protein complexes compared to protein alone. Nucleocapsid
derived from Ed N-522D retained the ability to form
nucleocapsid–hsp72 complexes in pre-conditioned cells,
despite loss of a functional hsp72 binding motif within Box-
3. Significant differences in the relative nucleocapsid
content of hsp72 between Ed N and Ed N-522D were not
observed in three separate experimental trials. Results
indicate that stable complex formation between hsp72 and
nucleocapsid is not dependent upon the ability of Box-3 to
bind hsp72 and that other binding sites must exist.
Co-immunoprecipitation of hsp72 and C-terminal deletion
constructs of N protein established a pivotal role of Box-2 to
hsp72 complex formation
Hep2 cells were transfected with plasmids directing the
T7-mediated expression of hsp72, N, N-522D, and N
protein deletion constructs lacking either Box-3 (ND3) or
both Box-2 and -3 (ND2,3). Immunoprecipitates were
generated from cell lysates using mouse monoclonal anti-
body against a VSV-G epitope tag on hsp72, demonstrating
recovery of N, N-522D, and ND3 by Western blot analysis
when co-expressed with hsp72 (Fig. 3). N protein was not
recovered in the absence of transfection with the hsp72
expression plasmid, confirming the specificity of these
results. Immunoprecipitates were also formed with antibody
against the amino terminus of N, and hsp72 was demon-
strated in the product by Western blot analysis (data not
shown). In contrast, hsp72 did not form precipitates with N
protein when both Box-3 and Box-2 were deleted (Fig. 3).
Western blot analysis of cell lysates confirmed that this lack
of recovery was due to loss of complex formation and not to
deficient expression of ND2,3. These findings confirm and
extend results of the nucleocapsid analysis, showing that
Box-3 is not required for hsp72 stable complex formation
whereas Box-2 is required. The yield of ND3 recovered inassociation with hsp72 was consistently less than that of N-
522D or parent N, indicating that the presence of a Box-3
stabilizes hsp72/N complexes independent of Box-3
sequence (i.e., parent Ed N or N-522D). Inability to recover
complexes between hsp72 and ND2,3 indicates that Box-1
plays little if any role in hsp72 binding.
A soluble monomeric form of the N protein C-terminus
(N-TAIL) modeled nucleocapsid–hsp72 binding reactions in
surface plasmon resonance analyses and confirmed loss of
hsp72 binding affinity following deletion of Box-2 and -3
but not introduction of a Box-3 sequence that was deficient
in hsp72 binding capacity
A recombinant, soluble monomeric form of the N protein
C-terminus (NTAIL, representing N amino acids 401–525)
and two variants of NTAIL were produced in bacteria. The
variants included NTAIL-522D and a previously described
truncation mutant lacking Box-2 and -3 (NTAILD2,3, N amino
acids 401–488) (Bourhis et al., 2004). As shown in Fig. 4,
the NTAIL proteins display an abnormally slow migration in
SDS–PAGE with an apparent molecular mass (MM) of
either 20 kDa (NTAIL, NTAIL522D) or 18 kDa (NTAILD2,3)
(expected MMs are 15.0 and 11.5 kDa, respectively). This
anomalous behavior, already documented for NTAIL and
NTAILD2,3 (Bourhis et al., 2004; Longhi et al., 2003), is
frequently observed in intrinsically disordered proteins and
can most likely be ascribed to their rather high content of
acidic residues (Tompa, 2002). The NTAIL and NTAIL522D
proteins displayed the same gel filtration elution profile
(data not shown), leading to an estimated RS of 27T3 A˚,
indicating that the substitution does not have a significant
effect on the compactness of the NTAIL structure.
Binding reactions between the NTAIL constructs and
purified human recombinant hsp72 were characterized by
real time protein–protein interaction analysis using surface
plasmon resonance technology (BIAcore 3000, Amersham
Pharmacia Biotech). Hsp72 was conjugated to the surface of
sensors as ligand and NTAIL proteins were passed over these
Fig. 4. BIAcore sensorgram (top panel) illustrating binding of NTAIL in solution to 1000 response units (RU) human recombinant hsp72 conjugated to CM5
sensor surfaces. One RU reflects a 1 ng/mm2 change in protein mass on the sensors. Sensorgrams are corrected for background interaction of NTAIL with flow
channels lacking hsp72 for each of the five concentrations (i.e., 1.25–20 AM) used in the global analysis of binding reactions. Experimental data were fitted to
reference curves (solid thin lines) derived from a well-characterized 1:1 ligand/substrate interaction model, with the difference between experimental and
reference data plotted as residuals (bottom panel). The quality of fitting is inherent in the small residuals that randomly distribute around zero for the association
(72–214 s) and dissociation (216–350 s) phases of the reaction. The analyses exclude spikes that occur at the beginning (64–72 s) and end (214–216 s) of the
NTAIL injections. The inset illustrates purity and electrophoretic mobility of NTAIL constructs used in the BIAcore analysis using Coomassie blue staining of a
12% SDS–PAGE loaded with approximately 5 Ag of purified NTAIL, NTAILD2,3, and NTAIL522D.
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recorded in real time as a change in plasmon resonance that
is recorded in response units (RU), where RU is propor-
tionate to the protein mass on the sensor. Non-specific
interactions between analyte and unmodified sensor surfaces
were subtracted from the plot of RUs, with the corrected
plot (i.e., sensorgram) illustrating association, equilibrium,
and dissociation phases of the binding reaction. Combined
analyses of sensorgrams recorded for a range of analyte
concentrations were compared to a reference bank, and high
quality fitting between experimental and reference data was
used to calculate reaction rate and equilibrium constants.
Reactions between NTAIL and hsp72 revealed high
quality fitting of experimental data to the Langmuir (1:1)
binding model (Fig. 4). Residuals plot the observed differ-
ence between experimentally derived sensorgrams and those
in a reference bank against which the experimental data are
being compared. The quality of fit was inherent in the smallresiduals that randomly distribute around zero for each data
point representing association and dissociation phases of the
reaction for all sensorgrams used in the combined analysis.
Similarly, the Chi2 values, which are the sum of squared
differences between experimental and reference data at each
point, were in the T 2 range, with values in the T10 range
reflecting a quality fit (Table 1).
NTAIL bound hsp72 with high affinity (KD = 11 nM), this
affinity being comparable to that previously described for
nucleocapsids isolated from the cytoplasm of Vero cells
infected with Ed-MV (KD = 16 nM) (Zhang et al., 2002).
Both association and dissociation rate constants describing
the hsp72 binding reaction were also comparable between
NTAIL (ka = 8.8  102/Ms, kd = 1.0  105/s) and
nucleocapsid (ka = 6.4  102/Ms, kd = 1.0  105/s),
indicating that the C-terminus of N contains the hsp72
binding sites that can model the binding reaction between
hsp72 and the surface of nucleocapsid.
Table 1
Calculated equilibrium dissociation constants (KD), on rate (ka) and off-rate (kd) between hsp72 and NTAIL proteins and peptides
Analyte Quality of fit ka (1/ms) kd (1/s) KD (M)
Residuals Chi2
NTAIL
a 1.2–1.6 0.150 8.8  102 1.0  105 1.1  108 (11 nM)
NTAIL-522D 2.0–2.0 1.130 8.9  102 1.0  105 1.1  108 (11 nM)
NTAILD2,3 1.2–1.4 0.165 6.0 2.3  105 3.8  106 (3.8 AM)
Box-1 peptide (aa 401–421)
(TTEDKISRAVGPRQAQVSFLH)
1.2–1.2 0.152 0.2 5.6  103 2.4  102 (24 mM)
Box-2 peptide (aa 487–507)
(DSRRSADALLRLQAMAGISEE)
2.4–1.8 0.806 4.1  102 1.0  105 2.4  108 (24 nM)
Box-3 peptide (aa 504–525)
(SEEQGSDTDTPIVYNDRNLLD)
0.5–0.6 0.069 1.4  102 4.9  104 3.6  106 (3.6 AM)
a Results were identical for NTAILHNFC and NTAILHN; binding was not influenced by the C-terminal Flag.
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significantly alter the binding between hsp72 and NTAIL,
illustrated by results obtained using NTAIL-522D as analyte
(Table 1). These results were consistent with the ability to
isolate Hsp72–nucleocapsid complexes from pre-condi-
tioned cells infected with Ed N-522D. In contrast, deletion
of Box-2 and Box-3 diminished the hsp72 binding capacity
of NTAIL (i.e., NTAILD2,3) by two orders of magnitude (KD =
3.8 AM), due primarily to a reduction in the hsp72 asso-
ciation rate. This result is similar to published findings,
where enzymatic removal of the N protein C-terminus from
nucleocapsids results in a decreased nucleocapsid affinity
for hsp72 (KD = 0.4 AM) that is associated with a slower
hsp72 association rate (Zhang et al., 2002). Collectively, the
results support a role for N protein aa 489–525 in high
affinity hsp72 complex formation with nucleocapsid, where
hsp72 binding capacity of Box-3 (aa 517–525) is not
required. Results thus support the role of the 489–516
region of NTAIL as mediator of high affinity NTAIL binding.
Box-2 peptides bind hsp72 with an affinity comparable to
that of NTAIL, in contrast to the low hsp72 affinity of Box-3
peptide and lack of physiologically relevant affinity by
Box-1 peptide
In order to confirm the primary role of Box-2 and
negligible role of Box-1 to high affinity hsp72 binding,
surface plasmon resonance analysis of peptide/hsp72 bind-
ing reactions was performed (Table 1). Peptide analytes
contained the sequence of Box-1, -2, or -3, and were 21
amino acids in length. This size permitted detection of
binding events over a broad range of analyte concentrations,
and the uniformity in analyte size facilitated comparisons of
reaction constants between peptides. The Box-3 peptide was
larger than the nominal length of the motif, including the
linker between Box-2 and Box-3 (amino acids 507–516),
but this additional sequence did not significantly influence
binding. Reaction constants were comparable between the
21-aa construct and those previously reported for a 15-aa
construct (amino acids 511–525) (Zhang et al., 2002), with
a KD of 3.6 versus 1.0 AM, a ka of 1.4  102 versus 3.5 
102/Ms, and a kd of 4.9 versus 4.1  104/s, respectively.The Box-2 peptide exhibited an hsp72 binding affinity (KD =
24 nM) that was 2 orders of magnitude greater than that of
Box-1 and Box-3 peptides, being comparable to that of
NTAIL. Box-1 peptide exhibited the lowest hsp72 binding
affinity with a KD of 24 mM, indicating that interactions with
hsp72 would not occur under physiological conditions. The
dominance of Box-2 in hsp72-NTAIL binding explains why
the latter reactions can be accurately modeled by a 1:1
ligand/substrate interaction model.
Hsp72 competitively inhibits binding of the P protein X
domain to NTAIL
The P protein X domain (XD) binds Box-2 of NTAIL in
support of transcription and genome replication (Bourhis et
al., 2004; Johansson et al., 2003; Kingston et al., 2004a,
2004b). The ability of hsp72 to compete with XD for NTAIL
binding was examined to demonstrate the specificity and
potential significance of hsp72/Box-2 interaction. Recombi-
nant hexahistidine-tagged hsp72 and hsp72 peptide binding
domains (PBD, amino acids 381–541) were expressed and
purified from the soluble fraction of E. coli. Both hsp72 and
PBD were recognized by mouse monoclonal antibody
(SPA-810, StressGen) and rabbit polyclonal antibody
(SPA-812, StressGen) specific to hsp72 (data not shown).
The NTAIL binding capacity of hsp72 was confirmed by
surface plasmon resonance analysis as described above,
whereas binding was not observed for PBD (data not
shown). XD was immobilized on sensor surfaces as ligand,
and NTAIL passed over these surfaces in solution either
alone, or with hsp72 in molar ratios of 1:2, 1:1, or 2:1. The
PBD was subsequently used as a negative control for the
competitive inhibition of NTAIL/XD binding, being intro-
duced at molar ratios of 1:2, 1:1, and 2:1 with NTAIL.
Generation and characterization of XD have been described
previously (Johansson et al., 2003).
Dosage-dependent inhibition of NTAIL binding to XD
was observed with hsp72:NTAIL ratios of 1:1 and 2:1, where
maximal signal observed with 20 AM NTAIL was reduced by
25% and 39%, respectively (Fig. 5). The same molar ratios
of PBD/NTAIL yielded 0% and 7% reductions in maximal
NTAIL binding to XD, demonstrating the specificity of the
Fig. 5. BIAcore sensorgrams illustrating binding of NTAIL in solution (20 AM) to 150 RU of the P protein X domain conjugated to CM5 sensor surfaces.
Sensorgrams illustrate competitive inhibition mediated by hsp72 (top panel), introduced together with NTAIL at an NTAIL/hsp72 molar ratio of 1:1 or 1:2. The
latter resulted in a reduction of maximal NTAIL binding (where no competitor is present) of 25% and 39%, respectively. A protein devoid of NTAIL binding
activity, a subunit of hsp72 that includes the peptide binding domain (PBD), was used as a negative control for the competitive inhibition (bottom panel). The
inset illustrates the purity and electrophoretic mobility of hsp72 and PBD using Coomassie blue staining of a 12% SDS–PAGE loaded with approximately 5 Ag
each of the purified proteins.
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hsp72:NTAIL did not yield a significant inhibition of NTAIL/
XD binding, potentially reflecting an excess of NTAIL
relative to the immobilized XD. These results further
support the identity of Box-2 as an hsp72 binding target
and demonstrate the potential of such interaction to modify
NTAIL binding of the viral polymerase cofactor P.
Ed N-522D virus exhibits increased levels of genomic RNA
on pre-conditioned cells
If hsp72/Box-2 interaction is functionally relevant, then
there should be an effect on viral genome and/or transcript
levels in virus-infected cells regardless of whether Box-3
can or cannot bind hsp72. To test this possibility, both
control and pre-conditioned Vero cells were infected with
either parent Ed N virus or the Ed N-522D variant in which
the hsp72 binding capacity of Box-3 is lost. Cells were
infected at an MOI of 1.0 and total cell RNA harvested at
24 h PI for Northern blot analysis of viral genome and
transcript levels. Signals were quantified by phosphorimage
analysis, corrected for variation in GAPDH signal, and the
results normalized so that mean signal from control cells
equaled one, allowing results from two separate experi-
mental trials to be combined. Genome levels were increased
on pre-conditioned relative to control cells for both parent
and Ed N-522D virus. The average difference was 1.85 T0.07- and 1.5 T 0.07-fold for Ed N and Ed N-522D,
respectively (Fig. 6). These increases were statistically
significant based upon a two-tailed t test of sample means
assuming unequal variance (P <0.05). In contrast, signifi-
cant increases in viral transcript levels on preconditioned
cells was observed only for the Ed N virus, being increased
an average of 1.70 T 0.10 for both N and H transcripts.
Transcripts for Ed N-522D were increased on pre-condi-
tioned cells by only 1.20 T 0.28 relative to infected control
cells, a non-significant difference. These results suggest that
Box-3 is primarily responsible for the effects of pre-
conditioning upon viral transcript levels, whereas increases
in viral genome levels involve additional viral determinants
that may include Box-2.Discussion
Our data indicate that hsp72 binds Box-2 with high
affinity, in contrast to a low but physiologically relevant
binding affinity for Box-3 and lack of significant affinity for
Box-1. High affinity binding between hsp72 and Box-2 of
NTAIL (KD = 11 nM) is consistent with the ability of hsp72–
nucleocapsid complexes to withstand CsCl isopycnic
density centrifugation, an isolation procedure that should
readily disrupt interactions mediated by Box-3. This does
not imply that hsp72 binding to Box-3 is irrelevant. Indeed,
Fig. 6. Northern blot analysis of MV genome and transcript levels on pre-
conditioned (PC) and non-conditioned control (C) Vero cells. Hyperthermic
pre-conditioning (43 -C, 1.5 h) was performed 16 h prior to infection with
Ed N and Ed N-522D variant virus at an MOI = 1.0 in duplicate treatment
groups. Total RNA was harvested at 24 h PI. Total RNA from uninfected
pre-conditioned cells was included as a control (U). The 15-kb genome was
detected with a negative strand-specific 32P-labeled riboprobe recognizing
the N gene, and the viral N and H transcripts were detected with plus
strand-specific riboprobes. A total of 5 Ag total cell RNA was loaded per
well, and signal from GAPDH transcript was used as a loading control.
Data are representative of two separate experimental trials. Quantification
of GAPDH-corrected signal intensities showed the increases in genome
levels on pre-conditioned cells to be statistically significant for both Ed N
and Ed N-522D viruses, whereas increases in N or H transcript levels were
significant only for Ed N.
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tion of MV minireplicon reporter gene expression (Zhang et
al., 2002), and the KD describing the binding reaction (1–3
AM) suggests a significant degree of intracellular association
when the stress response has been induced; the concen-
tration of soluble hsp72 has been estimated at 85 nM in Vero
cells following transient hyperthermic treatment (Oglesbee
et al., 1996). Co-immunoprecipitation of hsp72 and N
deletion constructs also suggest that Box-3 plays a role in
stabilizing hsp72/NTAIL complexes, independent of the
intrinsic hsp72 binding affinity of this element. For exam-
ple, the extreme C-terminal sequences that comprise Box-3
may influence NTAIL structure in such a way as to maximize
the strength of Box-2/hsp72 binding. In contrast, Box-1
appears to be irrelevant to hsp72–nucleocapsid complex
formation, based both upon the low affinity of Box-1
peptides for hsp72 and the inability of N proteins containingBox-1 but lacking Box-2 and Box-3 to pull down hsp72 in
co-immunoprecipitation experiments. The latter point also
rules out a significant contribution of the amino terminal
two-thirds of the N protein (i.e., NCORE) to nucleocapsid–
hsp72 complex formation. Although NCORE is highly
hydrophobic, making it an attractive target for cellular
chaperones, it also mediates the N–N protein association
that drives formation of nucleocapsid-like particles (Karlin
et al., 2002). Formation of these particles occurs sponta-
neously when N protein is expressed in transfected cells,
and our results suggest that NCORE–NCORE interactions out-
compete any hsp72-NCORE binding that might otherwise
occur.
Amino acids within the nominal Ed-MV Box-2 motif
(489-RRSADALLRLQAMGISE-506) that predict hsp72
binding are highly conserved among MV strains. Amino
acids that predict binding (i.e., R, L, I) and those that would
impose constraint (i.e., D, E) are either strictly conserved or
represented by conservative substitutions (e.g., D to E or R
to K) in 96 of 100 strains examined, representing genotypes
A–D and F–I (Kreis et al., 1997). An increase in the acidic
content is never observed and only four isolates exhibit a
decreased content of basic side groups (i.e., 489R to Q in
genotype E). Such strict sequence conservation within an
otherwise hypervariable protein domain is consistent with
the role of Box-2 as mediator of P binding in its function as
co-factor for transcription and genome replication. In
contrast, the nominal Box-3 sequence of Ed-MV (517-
VYNDRNLLD-525) exhibits a similar degree of conserva-
tion only within the group A genotype. With the exception
of Measles strain UK140/94 (genotype D8), all remaining
genotypes exhibit the 522N to D substitution that increases
the acidic content of the motif and disrupts hsp72 binding.
Although the precise contribution of individual residues to
binding remains to be determined, we can, based upon our
knowledge of sequence compositions favoring hsp72
interaction, predict that all MV strains will interact with
hsp72 through Box-2, whereas Box-2 and Box-3 interac-
tions will be largely restricted to the group A genotype, a
group that includes the wild-type Edmonston strain and all
derivative vaccine lineages.
The functional significance of hsp72 binding to Box-2
remains to be shown, although the importance of Box-2 as a
binding site for the P protein during transcription and
genomic replication has significant potential as a basis for
hsp72-dependent modulation of viral gene expression.
Kingston et al. have estimated the Box-2 affinity of P to
be significantly lower than that of hsp72 using isothermal
calorimetry to establish a KD of 13 AM for binding reactions
between the P protein X domain (XD, P amino acids 459–
507) and Box-2 (Kingston et al., 2004a). Using NTAIL
instead of Box-2 peptide, we have established binding
affinities for XD that are greater, more closely approximat-
ing the affinity of hsp72 for NTAIL; the affinity between
NTAIL and XD was based upon both BIAcore analysis (KD =
81 nM) and fluorescence spectroscopy (KD = 133 nM)
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data demonstrate that hsp72 can competitively inhibit
binding of XD to NTAIL. The magnitude of inhibition by
hsp72 supports the conclusion that the affinity between
XD and NTAIL is comparable to if not greater than that
between hsp72 and NTAIL. Such competitive inhibition is
highly likely within the context of a cell, given the
dynamic range of intracellular concentrations of hsp72
that can be encountered. Analysis of viral RNA
expression profiles supports the significance of hsp72/
Box-2 interactions. Parent virus exhibits both increased
genome and transcript levels when hsp72 is elevated. For
the N-522D virus containing an inactive (i.e., non-hsp72
binding) Box-3, there is no increase in viral transcript
levels on preconditioned cells whereas genome levels
remain responsive. Similar results have been obtained
following infection of murine neuroblastoma cell lines
that are stably transfected to overexpress hsp72 (Ogles-
bee, unpublished observation). These results support the
hypothesis that hsp72/Box-2 interactions influence
genome replication, although they do not address the
possibility that Box-2 binding may also be necessary for
increases in transcription otherwise mediated by hsp72/
Box-3 interaction.
The question arises as to why such an effect of hsp72/
Box-2 interaction was not detected in the minireplicon
system, where reporter gene expression supported by an N-
522D construct was not influenced by hsp72 supplementa-
tion (Zhang et al., 2002); the magnitude of reporter gene
expression in these systems reflects both transcription and
genome replication. The answer may lay in the high basal
expression of hsp72 that is characteristic of primate cell
lines used in the current and previous work. The mini-
replicon system documenting effects of hsp72/Box-3
interaction (as well as the current study using infectious
virus) compared conditions of basal versus supplemental
hsp72 levels, not the absence versus presence of hsp72. This
fact required use of a VSV-G-tagged hsp72 construct to
distinguish endogenous from supplemental hsp72 when the
latter is mediated by plasmid transfection. This construct
was essential in the hsp72/N co-immunoprecipitation
experiments of the present work to show that the antibody
pulling down hsp72 was not non-specifically binding N
(Fig. 3). When cells are transfected to express N but not a
VSV-tagged hsp72, the VSV-G antibody does not co-
precipitate N protein, whereas antibody against hsp72 will
co-precipitate low levels of N protein (data not shown).
Basal interaction is not illustrated by the analysis of purified
nucleocapsid, likely reflecting the tendency of CsCl
gradients to strip nucleocapsid of bound proteins including
P and L. Accordingly, hsp72–nucleocapsid complexes are
only preserved when isolated from cells containing high
hsp72 levels. In contrast to a stimulatory effect of hsp72/
Box-2 binding, competitive interaction between hsp72 and
P for NTAIL may have contributed to the paradoxical decline
in measles virus minireplicon reporter gene expression atexcessively high levels of hsp72 supplementation (Zhang et
al., 2002).
Collectively and in light of basal hsp72 expression
profiles and the high affinity hsp72/Box-2 interaction, our
data indicate that the basal amount hsp72 is not limiting
to any function mediated by Box-2/hsp72 binding in
minireplicons, whereas high levels of hsp72 are required
to support the low-affinity Box-3 interactions that result
in enhanced reporter gene expression. That high hsp72
levels are required to enhance genome replication for
infectious virus but not minireplicons may simply reflect
the 18-fold greater genome length of the former, placing
greater demands upon host cofactors (such as hsp72)
supporting genome replication (e.g., by enhancing poly-
merase processivity or encapsidation of nascent genomic
RNA). Elucidating the function of hsp72/Box-2 interac-
tions will ultimately require elimination of basal hsp72
expression and/or selective disruption of Box-2 binding
by hsp72.Methods
Generation of Ed N-522D virus
Ed-MV carrying the 522D substitution in the N protein
(N-522D) was generated by oligonucleotide site-directed
mutagenesis of the full-length MV genomic cDNA plasmid
(p + MV) (Radecke et al., 1995). Oligonucleotide site-
directed mutagenesis was performed on a subclone of the
full-length MV genomic cDNA, a 2310-bp SfiI–SacII
fragment that represented the complete N gene and 239 bp
of the 5V P gene coding region. Mutagenic primers
incorporated additional nucleotide substitutions that did
not affect coding but did add a BsmAI site to facilitate
screening of transformants by restriction analysis of plasmid
DNA. The sequence of the mutagenic primers and the
procedures for mutagenesis have been previously described
(Zhang et al., 2002). Bidirectional sequence analysis of the
N/P subclone used a fluorescence-automated 3700 DNA
analyzer (Applied Biosciences Inc.) and Big-Dye Termi-
nator cycle sequencing chemistry to confirm the presence of
the desired mutations and rule out the presence of second
site mutations (Zhang et al., 2002). Variant N/P fragments
were exchanged for parent sequence in the genomic cDNA
and the resultant plasmid designated p + MV-N522D.
Infectious virus was rescued from Hep-2 cells according
to the procedure of Parks et al. (1999, 2002). Cells were
transfected to express plus sense MV genomic RNA (+MV-
N522D), and N, P, and L messenger RNA. Ed N-522D virus
was rescued on Vero cells in parallel with the parental virus
(Ed N, derived from plasmid +MV), plaque purified, and
used to generate low-passage pools. Sequence analysis of
genomic RNA from these viral pools confirmed the
presence of the desired C-terminal N gene mutation and
lack of spurious second site mutations.
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Viral nucleocapsid was isolated from the cytoplasm of
pre-conditioned and non-conditioned control Vero infected
at an MOI of 0.01. The isolation procedure has been
previously described in the analysis of hsp72/nucleocapsid
complexes using CsCl isopycnic density centrifugation as
the final purification step (Oglesbee et al., 1989b). Gradients
were divided into 250-Al fractions using an ISCO Density
Gradient Fractionator, generating continuous 254-nm light
absorbance profiles (Lin et al., 2001). Fraction sample
densities were computed from the refractive indices
(Oglesbee et al., 1989b). Western blot analysis of dialyzed
samples was performed in order to detect hsp72 and viral N
protein, the latter using an N protein-specific monoclonal
antibody (Zhang et al., 2002). Total RNA was also isolated
from nucleocapsid containing fractions to confirm presence
of genomic RNA by Northern blot analysis.
Co-immunoprecipitation of hsp72 and N protein variants
Hep2 cells in duplicate wells of 6-well plates were
transfected with plasmids supporting the T7-mediated
expression of Hsp72 (pT7VSV-Hsp72) and either MV N
(pT7MV-N), N-522D (pT7MV-ND4D), N protein lacking
Box-3 (pT7MV-NC-9), or N protein lacking Box-3 and the
C-terminal two-thirds of Box-2 (pT7MV-NC-31) as pre-
viously described (Zhang et al., 2002). Cells were infected
with MVAT7 at an MOI of 2 concurrent with transfection
and harvested at 30 h post-transfection. The protocol for
immunoprecipitation of hsp72-associated protein has been
previously established (Seidberg et al., 2003). Briefly, cells
were scraped into immunoprecipitation lysis buffer (0.1 M
NaCl, 0.01 M Tris pH 7.0, 0.1 M EDTA, 2 Ag/ml
chymotrypsin, 2 Ag/ml leupeptin, 2 Ag/ml pepstatin, and
100 Ag/ml PMSF), disrupted using a Dounce homogenizer,
and the lysates clarified by centrifugation at 10,000  g for
10 min, 4 -C. Lysates were pre-cleared by adding 0.25 Ag/
ml mouse IgG and 20 Al of a 25% v/v Protein A/G agarose
mixture per ml of lysate, then incubated at 4 -C for 30 min,
followed by centrifugation at 1000  g for 30 s. Total
protein concentration was determined using the BCA assay,
and 150 Ag of total protein was used for immunoprecipi-
tation with mouse monoclonal antibody recognizing the
VSV-G epitope on the recombinant hsp72 (P5D4, Boeh-
ringer Mannheim). The final antibody concentration was
0.25 Ag/ml. Immune complexes were recovered with protein
A/G agarose, and pellets washed 4 with RIPA buffer. The
N protein content in the pellet was determined by Western
blot analysis using anti-N monoclonal antibody specific to
the amino terminus of the molecule (Birrer et al., 1981). The
antibody was directly conjugated to horseradish peroxidase
and the signal detected by chemiluminescence. The same
antibody was used in the Western blot analysis of clarified
cell lysates to establish the level of N protein expression
within transfected cells. The procedure was repeated usingthe anti-N monoclonal antibody for the immunoprecipitation
and hsp72-specific monoclonal SPA 810 (StressGen) to
detect hsp72 in the precipitate.
Generation of NTAIL constructs and purification of NTAIL
proteins
All NTAIL constructs were obtained by PCR amplification
of the MV N gene, strain Edmonston B. The intermediary
NTAILHN gene construct, encoding residues 401–525 of the
MV N protein with a hexahistidine tag fused to its N-
terminus, was obtained using the plasmid pET21a/N
(encoding the MV N protein) as template (Karlin et al.,
2002). Forward primer (5V-gatagaaccatgCATCATCATCAT-
CATCAtactactgaggacaagatcagtaga-3V) was designed to
introduce the hexahistidine tag encoding sequence (upper
case) at the N-terminus of NTAIL, while reverse primer (5V-
ggggaccactttgtacaagaaactgggtcttagtctagaagtttctgtcattgta-
3V) was designed to introduce an AttB2 site (bold). The PCR
amplification product was further used as template in a
second PCR step using forward primer (5V-ggggacaag-
tttgtacaaaaaagcaggcttcgaaggagatagaaccatgCATCATCA-
TCAT-3V) to introduce an AttB1 site (bold), and reverse
primer as above. The PCR product was cloned into the
pDest14 vector (Invitrogen) using the Gateway recombina-
tion system (Invitrogen), yielding pDest14/NTAILHN.
The NTAILHNFC gene construct incorporating a C-terminal
Flag sequence (dykddddk) was obtained using the plasmid
pDest14/NTAILHN as template. Forward primer (5V-
ggggacaagtttgtacaaaaaagcaggcttcgaaggagatagaaccatg-
CATCATCATCAT-3V) was designed to introduce an AttB1
site (bold) and reverse primer (5V-gtcttaTTTGTCGTCA-
TCGTCTTTATAATCgtctagaagatttctgtcattgta-3V) was
designed to introduce the Flag encoding sequence (upper
case). The PCR amplification product was further used as
template in a second PCR step using the same forward
primer as above and reverse primer (5V-ggggaccactttgta-
caagaaagctgggtcttaTTTGTCGTCATCGTCTTT-3V), which
was designed to introduce an AttB2 site (bold). After
purification, the PCR product was cloned into the pDest14
vector to yield pDest14/NTAILHNFC.
Generation of the NTAILD2,3 gene construct, encoding
residues 401–488 of the MV N protein with an N-terminal
hexahistidine tag plus a C-terminal Flag sequence, has been
previously described, where it was referred to as NTAIL2
(Bourhis et al., 2004). The NTAILD522 gene construct,
encoding residues 401–525 of the MV N protein with an
N to D substitution at position 522 and with a hexahistidine
tag fused to its N-terminus, was obtained by PCR using the
plasmid pET21a/N as template. Two separate PCR steps
were carried out in parallel, yielding amplification products
A and B. Product A was obtained using forward primer (5V-
gatagaaccatgCATCATCATCATCATCATactactgaggacaagat-
cagtaga-3V) to introduce the N-terminal hexahistidine tag
(upper case) while reverse primer (5V-ttcttagtctagaagATCt-
ctgtcattgtacaa-3V) introduced an asparagine at position 522
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Product B was obtained using forward primer (5V-gtgtacaat-
gacagaGATcttctagactaagaa-3V) to introduce an aspartic acid
at position 522 (bold and upper case) and a BglII site
(underlined), and the reverse primer (5V-ccgggcatgcatccgga-
tatagttcctcctt-3V) was designed to anneal with nucleotide
positions 1755–1775 of pet21a/N (where the A of the ATG
codon of the N ORF was set as nucleotide position 1). A
further PCR step was carried out using amplification
products A plus B as template to yield the NTAIL D522
amplification product. Forward primer (5V-ggggacaagtttg-
tacaaaaaagcaggcttcgaaggagatagaaccatgCATCATCATCAT-
3V) introduced an AttB1 site (bold) while reverse primer (5V-
ggggaccac t t t t g tacaagaaagc tg gg t c t t ag t c t aga -
agATCtctgtcattgta-3V) introduced an AttB2 site (bold) and
an aspartic acid at position 522 (upper case). The amplicon
was then cloned into the pDest14 vector using the Gateway
recombination system. The final construct was referred to as
pDest14/NTAILD522. Candidate clones bearing the desired
mutation were selected on the basis of the ability of their
recombinant plasmids to excise a 0.5-kb BglII fragment due
to the presence of a second BglII site introduced by PCR
together with the N to D substitution.
The E. coli strain DH5a (Stratagene) was used for
selection and amplification of DNA constructs. The
sequence of the coding region of all expression plasmids
was verified (MilleGen, France). The E. coli strains
Rosetta [DE3] pLysS (Novagen) were used for expression
of recombinant proteins. Since the MV N gene contains
several rare codons that are used with a very low
frequency in E. coli, co-expression of NTAIL constructs
with the plasmid pLysS (Novagen) was carried out. This
plasmid, which supplies six rare tRNAs, carries also the
lysozyme gene, thus allowing a tight regulation of the
expression of the recombinant gene, as well as a facilitated
lysis. Cultures were grown overnight to saturation in LB
medium containing 100 Ag/ml ampicillin and 17 Ag/ml
chloramphenicol. An aliquot of the overnight culture was
diluted 1/25 in LB medium and grown at 37 -C. At OD600
of 0.7, isopropyl ß-d-thiogalactopyranoside (IPTG) was
added to a final concentration of 0.2 mM, and the cells
were grown at 37 -C for 3 h.
In all cases, the majority of recombinant protein was
recovered from the soluble fraction of bacterial lysates (data
not shown). The NTAIL proteins were purified to homoge-
neity (>95%) in 2 steps: immobilized metal affinity
chromatography (IMAC) and gel filtration (GF). Cellular
pellets from bacteria transformed with different NTAIL
expression plasmids were disrupted by sonication (using a
750-W sonicator and 4 cycles of 30 s each at 60% power
output) in 5 volumes (v/w) buffer A (50 mM sodium
phosphate pH 8, 300 mM NaCl, 10 mM Imidazole, 1 mM
PMSF) supplemented with lysozyme 0.1 mg/ml, DNAse I
10 Ag/ml, protease inhibitor cocktail (Sigma) (50 Al/g cells).
The lysate was clarified by centrifugation at 30,000  g for
30 min. Starting from a 1-L culture, the clarified supernatantwas incubated for 1 h with gentle shaking with 4 ml
Chelating Sepharose Fast Flow Resin preloaded with Ni2+
ions (Amersham Pharmacia Biotech), previously equili-
brated in buffer A. The resin was washed with buffer A, and
the NTAIL proteins were eluted in buffer A containing 250
mM imidazole. Eluates were analyzed by SDS–PAGE.
Fractions containing the recombinant product were concen-
trated using Centricon Plus-20 (molecular cutoff: 5000 Da)
(Millipore). The proteins were then loaded onto a Superdex
75 HR 10/30 column (Amersham Pharmacia Biotech) and
eluted in either 10 mM Sodium Phosphate pH 7 or 10 mM
HEPES pH 7.
Apparent molecular mass of proteins eluted from gel
filtration columns was deduced from a calibration carried
out with LMW and HMW calibration kits (Amersham
Pharmacia Biotech). Protein concentrations were calculated
either using the theoretical absorption coefficients E (mg/ml
cm) at 280 nm as obtained using the program ProtParam at
the EXPASY server (http://www.expasy.ch/tools), or the
Bio-Rad protein assay reagent (Bio-Rad).
Generation of hsp72 constructs and purification of hsp72
proteins
The Hsp72 constructs were obtained by PCR amplifica-
tion of the human Hsp72 gene (accession number M59828).
The Hsp72 construct, encoding the full-length Hsp72
protein with a hexahistidine tag fused to its N-terminus,
was obtained using the plasmid pT7VSV-Hsp72 (Zhang et
al., 2002) as template. Forward primer (5V-gatagaaccatg-
CATCATCATCATCATCATgccaaagccgcggcagtcggcatcgac-
3V) was designed to introduce the hexahistidine tag encoding
sequence (upper case) at the N-terminus of Hsp72 while
reverse primer (5V ggggaccactttgtacaagaaagctgggt-
cttaatctacctcctcaatggtggggcc-3V) was designed to introduce
an AttB2 site (bold). The PCR amplification product was
further used as template in a second PCR step using forward
p r ime r ( 5V- g g gga ca ag t t t g t a c aa aaaag cagg c t -
tcgaaggagatagaaccatgCATCATCATCAT-3V) to introduce an
AttB1 site (bold) and reverse primer as above. The PCR
product was cloned into the pDest14 vector (Invitrogen)
using the Gateway recombination system (Invitrogen),
yielding pDest14/Hsp72HN.
The Hsp72 PBD gene construct encoding the peptide
binding domain of Hsp72 (PBD, aa 381–541) (Wang et al.,
1993) with a hexahistidine tag fused to its C-terminus was
obtained using the plasmid pT7VSV-Hsp72 (Zhang et al.,
2002) as template. Forward primer (5V-ggggacaagtttgta-
caaaaaagcaggcttcgaaggagatagaaccatgaagtccgagaacgtgcag-
gac-3V) was designed to introduce an AttB1 site (bold) and
reverse primer (5V-ggggaccactttgtacaagaaagctgggtcttaAT-
GATGATGATGATGATGctccagggcgttcttggctgacac-3V) was
designed to introduce the hexahistidine tag encoding
sequence (upper case) and an AttB2 site (bold). After
purification, the PCR product was cloned into the pDest14
vector to yield pDest14/Hsp72 PBDHC.
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concentration of the recombinant hsp72 and PBD were the
same as described for the NTAIL constructs. For both Hsp72
constructs, the majority of the recombinant protein was
recovered from the soluble fraction of bacterial lysates (data
not shown). While the full-length Hsp72 protein was eluted
from the gel filtration column as a very broad peak,
indicative of oligomeric heterogeneity, the Hsp72 PBD
was mainly eluted as a sharp peak corresponding to a
monomeric form (data not shown).
The degree of folding of both Hsp72 proteins was
checked using circular dichroism, which allowed estimation
of the a-helical content of both Hsp72 proteins (data not
shown). CD spectra were recorded on a Jasco 810 dichro-
graph using 1-mm-thick quartz cells in 10 mM sodium
phosphate pH 7 at 20 -C. CD spectra were measured
between 185 and 260 nm at 0.2 nm/min and were averaged
from three independent acquisitions. Mean ellipticity values
per residue ([H]) were calculated as [H] = 3300 m DA/(l c
n), where l (path length) = 0.1 cm, n = number of residues,
m = molecular mass in Da, and c = protein concentration
expressed in mg/ml. Numbers of residues (n) are 647 for
Hsp72 and 167 for Hsp72 PBD, while m values are 70,861
Da for Hsp72 and 18,528 Da for Hsp72 PBD. Protein
concentrations of 0.1 mg/ml were used. The a-helical
content was derived from the ellipticity at 220 nm as
described by Morris et al. (1999). The calculated content
turned out to be roughly in accord with the expected value
estimated from the crystal structure of the Hsp72 ATPase
domain (pdb code 1HJO) (Osipiuk et al., 1999) and the
NMR structure of the PBD of Hsp72 (pdb code 1CKR)
(Morshauser et al., 1999).
BIAcore analysis of binding reactions
Real-time analysis of hsp72 binding reactions using
BIAcore 3000 instrumentation (Amersham Pharmacia Bio-
tech) has been previously described by our group (Zhang
and Oglesbee, 2003; Zhang et al., 2002). Peptide analytes
(i.e., binding partners in solution) were custom synthesized
(Genemed Synthesis Inc., San Francisco, CA.), purified to
>95%, and characterized by HPLC and mass spectroscopy.
Purified recombinant protein representing NTAIL variants
was also generated for use as analyte (described above).
Purified human recombinant hsp72 (StressGen) (5.0 Ag/
ml in acetate buffer pH 5.5) was covalently bound to
carboxy-methyl groups of CM5 sensor chips using amine-
coupling chemistry (Biosensor AB, Amersham Pharmacia
Biotech). The levels of immobilized hsp72 depended upon
the size of the analyte; binding of peptide analytes required
higher immobilization levels (10,000 response units, RU) as
compared to NTAIL proteins (1000 RU) in order to detect
binding events, where 1000 RU equals a change in mass of
1 ng/mm2 on the sensor surface. Reactions were performed
at 25 -C. Remaining flow channels on the sensor chip
included a control for non-specific interactions betweenanalyte and the sensor surface (i.e., activated/blocked flow
channel) and analyte and irrelevant protein targets (i.e.,
lactoferrin conjugated flow channel). Protein and peptide
analytes were passed over the sensor chip in HBS-P buffer
(0.01 M HEPES pH 7.4, 0.15 M NaCl, 0.005% surfactant P-
20) containing 2.5 mM magnesium acetate and 2.5 mM
ATP. Sensorgrams plotted changes in surface plasmon
resonance (measured in RU) as a function of time.
Multiple sensorgrams representing various analyte con-
centrations were analyzed by using BIAevaluation 3.1
software. Fitting of experimental data to well-characterized
binding reactions was used to define reaction rate and
equilibrium constants. Signal changes on the activated/
blocked control channel were subtracted from the peptide–
hsp72 and NTAIL protein–hsp72 interactions using in-line
reference and the subtracted sensorgrams were analyzed.
Kinetic and equilibrium constants were calculated from
global analysis of reactions with multiple analyte concen-
trations (25, 50, 100, and 200 AM in the case of peptides,
and 1.25, 2.5, 5, 10, and 20 AM in the case of NTAIL
proteins). Curves generated with serial analyte concentra-
tions were applied to the Langmuir binding model.
Competitive inhibition experiments used XD immobi-
lized to CM5 sensor chips at 150 RU, a level used
successfully in calculating binding affinity to NTAIL (Ogles-
bee and Longhi, unpublished observation). Buffer condi-
tions were the same as described for the analysis of hsp72/
NTAIL binding reactions. Strong signal is obtained using 20
AM NTAIL, and this concentration was used to measure
inhibition of binding by the hsp72 and/or PBD proteins
that were generated as described above. The same hsp72
constructs were immobilized to flow channels in parallel
with the XD-containing channel to confirm the NTAIL
binding ability of hsp72 and to show lack of binding by
the PBD. Background reflecting non-specific interactions
between analyte and sensor surfaces was subtracted from
all sensorgrams.
Analysis of viral RNA expression
Levels of viral transcript and genomic RNA were
quantified by Northern blot analysis of total cell RNA as
previously described (Vasconcelos et al., 1998a, 1998b).
Subconfluent cell monolayers were infected at MOIs
ranging from 0.01 to 5.0 and total RNA harvested between
12 and 24 h post-infection (Purescript RNA Isolation Kit,
Gentra). All time points represent samples that were infected
and subsequently analyzed in duplicate. Viral minus and
plus strand-specific [a32P]UTP-labeled riboprobes were
prepared from Ed-MV N and H cDNAs as described by
Rota et al. (1994). The blots were first hybridized with
riboprobe detecting minus sense genome, the signal
quantified by phosphorimager analysis, the blots stripped
(Strip-EZ RNA kit, Ambion), and the membranes subse-
quently probed for H, with the procedure being repeated for
the detection of viral N signal. Equivalent loading was
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from a 359-base riboprobe derived from the mouse GAPDH
coding sequence (pTRI-GAPDH-Mouse, Ambion).Acknowledgments
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